Pro Medicus Ltd (ASX: PME) Share Price and News

Dr Hupert is a medical practitioner and commenced general practice in 1980. He left general practice in 1984.

Mr Hall has been involved in the development of the software systems that underpin Visage RIS.

Mr Kempen is Chairman of the Australasian Leukemia and Lymphoma Group. He is also a Trustee of the Barr Family Foundation and a member of the Boards of St Hilda's College Ltd, University of Melbourne, and the Olivia Newton-John Cancer Research Institute. He has previously been Chairman of Ivanhoe Grammar School and Managing Partner of Ernst and Young Corporate Finance Australia. He was appointed a Member in the General Division of the Order of Australia (AM) in 2018.

Ms Williams is a non-executive director of the Australian Submarine Corporation (ASC Pty Ltd) and Mercer Investments Australia Ltd. She is Chair of the Audit and Risk Committee of ASC and a member of the Audit and Risk Committee and Due Diligence Committee of Mercer Investments Australia Ltd. She holds board positions with Tobacco Free Portfolios and is a non-executive director of Swimming Australia. Previous roles include Director and Chair of the Audit Committee of Cooper Energy, Non-Executive Director of the Vocus Group, and member of the Foreign Investment Review Board. Ms Williams serves on the People and Culture committee.

Ms Shiff is an Independent Board Member of GAVI, Chairman of AROSE (Australian Remote Operations in Space and Earth), Chairman of the Australian Telecommunications Alliance, and Chairman of the Care Economy Cooperative Research Centre. She also chairs the International Advisory Board of the Australian Research Centre of Excellence on Automated Decision Making and Society. Previous board roles include Chairman of the global board of BAI Communications, board member of Infrastructure Australia, Deputy Chairman of the Government's Export Credit Agency EFIC, as well as board roles in a number of venture capital-backed ICT companies. Deena has served as a Group Managing Director at Telstra, where she led the Wholesale Division Group, established and led Telstra Business, and founded Telstra Ventures. She has also held regulatory and legal positions and has been a Partner of the law firm Mallesons Stephen Jaques. She is the Chair of the People and Culture Committee.

Mr Glenning is a fund adviser to Skalata Ventures, investing in early-stage companies. He has previously been an Investment Director at Starfish Ventures and was the founder and Chief Executive Officer of Tonic Systems and a founding Non-Executive Director of Cameron Systems. He has also held software engineering positions at Google and Sun Microsystems Inc. He also serves on the People and Culture committee.

Dr Farrell is the Managing Director of AdNED Pty Ltd, a non-executive director of Ena Respiratory Pty Ltd and Axelia Oncology Pty Ltd, a member of the Walter and Eliza Hall Institute of Medical Research Board Commercialisation Committee, a member of the Scientific and Industry Advisory Committee of the Australian Research Council Centre for Cryo-electron Microscopy of Membrane Proteins, and a member of the Investment Committee for the CUREator Plus Dementia and Cognitive Decline Grants. He is also Chairman and a Board Director of Vitrafy Life Sciences. He was previously Head of Health Security Systems Australia, a division of DMTC Ltd, and Senior Vice President, Commercial of Certara USA, Inc. He was also Chairman and Chief Operating Officer of d3 Medicine LLC. Prior to these appointments, he was Vice President of Global Business Development at Biota Pharmaceuticals, Associate Director at GBS Venture Partners, Research Manager at Johnson and Johnson Research, and Chief Executive Officer of Gene Shears Pty Ltd. He is the member of People and Culture Committee.

-

-